Literature DB >> 14718642

Delay in onset of prion disease for the HY strain of transmissible mink encephalopathy as a result of prior peripheral inoculation with the replication-deficient DY strain.

Jason C Bartz1, Judd M Aiken2, Richard A Bessen1.   

Abstract

We report that the replication-deficient DY strain of transmissible mink encephalopathy (TME) can delay disease caused by the pathogenic HY TME strain. In this study, competition between the HY and DY TME agents was investigated following superinfection of the sciatic nerve and peritoneal cavity. Initially, DY TME infection was examined in the absence of superinfection and it was found that inoculation into the brain and sciatic nerve resulted in prion disease and PrP(Sc) deposition in brain but not lymphoreticular tissues. Conversely, intraperitoneal inoculation of the DY TME agent did not result in clinical symptoms, DY TME agent replication or PrP(Sc) deposition 400-600 days after infection. These findings indicate that the DY TME agent does not replicate in secondary lymphoid organs and is non-pathogenic when neuroinvasion is dependent on prior infection of the lymphoreticular system. However, intraperitoneal inoculation of the DY TME agent at 60 days, but not at 30 days, prior to intraperitoneal inoculation of the HY TME agent resulted in an extension of the HY TME incubation period. Inoculation of the DY TME agent into the sciatic nerve at 60 days prior to intrasciatic nerve inoculation of the HY TME agent did not delay the incubation period of HY TME. The ability of the DY TME agent to delay HY TME infection following extraneural inoculation, but not neural infection, suggests that HY and DY TME agent competition can occur in a common replication site whose cellular location precedes infection of both the lymphoreticular and peripheral nervous systems.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718642     DOI: 10.1099/vir.0.19394-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  29 in total

1.  In vitro generation of high-titer prions.

Authors:  Ronald A Shikiya; Jason C Bartz
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

Review 2.  The prion strain phenomenon: molecular basis and unprecedented features.

Authors:  Rodrigo Morales; Karim Abid; Claudio Soto
Journal:  Biochim Biophys Acta       Date:  2006-12-15

Review 3.  Prion propagation: the role of protein dynamics.

Authors:  John A Pezza; Tricia R Serio
Journal:  Prion       Date:  2007-01-10       Impact factor: 3.931

Review 4.  Tracking protein aggregate interactions.

Authors:  Christina J Sigurdson; Jason C Bartz; K Peter R Nilsson
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

Review 5.  Biology and Genetics of PrP Prion Strains.

Authors:  Sina Ghaemmaghami
Journal:  Cold Spring Harb Perspect Med       Date:  2017-08-01       Impact factor: 6.915

6.  Extraneural prion neuroinvasion without lymphoreticular system infection.

Authors:  Jason C Bartz; Crista Dejoia; Tammy Tucker; Anthony E Kincaid; Richard A Bessen
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Prion interference is due to a reduction in strain-specific PrPSc levels.

Authors:  Jason C Bartz; Michelle L Kramer; Meghan H Sheehan; Jessica A L Hutter; Jacob I Ayers; Richard A Bessen; Anthony E Kincaid
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  Nonpathogenic Heterologous Prions Can Interfere with Prion Infection in a Strain-Dependent Manner.

Authors:  Alba Marín-Moreno; Patricia Aguilar-Calvo; José Luis Pitarch; Juan Carlos Espinosa; Juan María Torres
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

9.  Prions of ruminants show distinct splenotropisms in an ovine transgenic mouse model.

Authors:  Thierry Baron; Anna Bencsik; Eric Morignat
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

Review 10.  Prion interference with multiple prion isolates.

Authors:  Charles R Schutt; Jason C Bartz
Journal:  Prion       Date:  2008-04-18       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.